JP Morgan Maintains Neutral on Arena Pharmaceuticals, Lowers Price Target to $58

JP Morgan maintains Arena Pharmaceuticals (NASDAQ:ARNA) with a Neutral and lowers the price target from $59 to $58.

Benzinga · 11/08/2019 13:31

JP Morgan maintains Arena Pharmaceuticals (NASDAQ:ARNA) with a Neutral and lowers the price target from $59 to $58.